Atlas Trials

Vascular Endothelial Growth Factor (VEGF) Levels in Retinal Vein Occlusion (RVO) During Anti-VEGF Treatment

Clinical trial NCT04707625 · TERMINATED

Trial details

NCT number
NCT04707625
Sponsor
Wake Forest University Health Sciences
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Retinal Vein Occlusion
Start date
2021-10-06
Primary completion
2023-12-18
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.